TickrTrends HSTM fair value analysis

HealthStream Q2 Earnings Call Highlights

finance.yahoo.com · 2026-08-04

HealthStream (NASDAQ:HSTM) reported record second-quarter revenue and adjusted EBITDA for 2026, citing growth in core subscription products, contributions from recent acquisitions and a one-time revenue catch-up tied to customer cost savings. The healthcare workforce technology company also raised i

TickrTrends take: HealthStream operates in the Healthcare sector and is currently assessed by TickrTrends as undervalued based on its derived valuation metrics. A valuation-focused reader monitoring HSTM should pay particular attention to whether the company's Q2 earnings call reveals trends in revenue growth, margin expansion, or cash flow generation that might justify or challenge the undervalued designation. Given the company's position in healthcare, operational metrics related to customer retention, subscription renewals, and software implementation progress would be especially relevant to tracking whether the current valuation reflects the company's true earning power.

Read the full story at finance.yahoo.com →

Is HSTM undervalued? See TickrTrends' fair value analysis →